Effect of Carmeda® bioactive surface coating versus Trillium ™ biopassive surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass

Perfusion

Volumn 16, Issue 4, 2001, Pages 279-283

  Palanzo, D A ^a   Zarro, D L ^a   Manley, N J ^a   Montesano, R M ^a   Quinn, M ^a   Elmore, B A ^a   Gustafson, P A ^a   Castagna, J M ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; HEMOGLOBIN; HEPARIN; POLYMER;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HEMATOCRIT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OXYGENATOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TIME; COMPARATIVE STUDY; FEMALE; INSTRUMENTATION; MALE; MIDDLE AGED; STANDARD; SURFACE PROPERTY;

AGED; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; OXYGENATORS, MEMBRANE; PLATELET COUNT; POLYMERS; SURFACE PROPERTIES;

EID: 0034743341     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600403     Document Type: Article

References (17)

1. Effect of surface coating on platelet count drop during cardiopulmonary bypass
2. Effect of Trillium™ Biopassive Surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass
3. Biocompatibility of a heparin-bonded membrane oxygenator (Carmeda MAXIMA) during the first 90 minutes of cardiopulmonary bypass: Clinical comparison with the conventional system
4. The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption
5. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass
6. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
7. Centrifugal pump and heparin coating improves cardiopulmonary bypass compatibility
8. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
9. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations
10. Heparin-coated versus non-coated surfaces for extracorporeal circulation
11. The effects of heparin bound surface modification (Carmeda Bioactive Surface) on human platelet alterations during simulated extracorporeal circulation
12. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass
13. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery
14. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro
15. Heparin-coated circuit in coronary surgery. A clinical study
16. Potential problem when using the new lower-prime hollow-fiber membrane oxygenators with uncoated stainless steel heat exchangers
17. Albumin in the cardiopulmonary bypass prime: How little is enough?